Skip to content
Screener

Erasca, Inc. ERAS Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$154.49M+16.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$33.57M
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$28.6M+10.1%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$956K-16.7%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$5.9M-25.0%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN
$254.83M

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Year ending December 31,Operating Lease PaymentsOperating Sublease Receipts
20279,1992,970
20289,2771,448
20299,5721,237
20309,878
Thereafter15,649
Total lease payments or sublease receipts$60,391$7,825
Less: Amount representing interest(14,438)
Operating lease liabilities$45,953

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s operating lease liabilities (total)?
Erasca, Inc. (ERAS) reported operating lease liabilities (total) of $45.95M in Q1 2026.
How has Erasca, Inc.'s operating lease liabilities (total) changed year-over-year?
Erasca, Inc.'s operating lease liabilities (total) decreased by 9.6% year-over-year, from $50.81M to $45.95M.
What is the long-term trend for Erasca, Inc.'s operating lease liabilities (total)?
Over 4 years (2021 to 2025), Erasca, Inc.'s operating lease liabilities (total) has grown at a 25.9% compound annual growth rate (CAGR), from $18.79M to $47.14M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Erasca, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude